These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28412211)

  • 1. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
    Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Li Y; Qi X; Liu X; Liang W; You K; Zhang Y; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():911-917. PubMed ID: 28178621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.
    Raychaudhuri M; Bronger H; Buchner T; Kiechle M; Weichert W; Avril S
    Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab.
    Liu B; Su F; Lv X; Zhang W; Shang X; Zhang Y; Zhang J
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1039-1049. PubMed ID: 31482230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
    Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
    Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.
    Li Q; Liu M; Ma F; Luo Y; Cai R; Wang L; Xu N; Xu B
    PLoS One; 2014; 9(8):e104870. PubMed ID: 25137071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
    Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
    PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.
    Peng J; Lin Y; Sheng X; Yuan C; Wang Y; Yin W; Zhou L; Lu J
    BMC Cancer; 2024 Jul; 24(1):789. PubMed ID: 38956544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
    Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
    Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
    Luengo-Gil G; García-Martínez E; Chaves-Benito A; Conesa-Zamora P; Navarro-Manzano E; González-Billalabeitia E; García-Garre E; Martínez-Carrasco A; Vicente V; Ayala de la Peña F
    Cell Oncol (Dordr); 2019 Oct; 42(5):627-644. PubMed ID: 31115881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
    Müller V; Gade S; Steinbach B; Loibl S; von Minckwitz G; Untch M; Schwedler K; Lübbe K; Schem C; Fasching PA; Mau C; Pantel K; Schwarzenbach H
    Breast Cancer Res Treat; 2014 Aug; 147(1):61-8. PubMed ID: 25086636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
    Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
    Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
    Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
    Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients.
    Shi GL; Zhang XY; Chen Y; Ma S; Bai WQ; Yin YJ
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer.
    Wang H; Tan G; Dong L; Cheng L; Li K; Wang Z; Luo H
    PLoS One; 2012; 7(4):e34210. PubMed ID: 22523546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.